Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Since youre absorbing smaller amounts over time, it may take longer to notice improvements
In the future, priority should be given to advancing clinical trials, optimizing injectable formulations and administration regimens, addressing environmental and cost issues in production, and strengthening synergistic research with other preparations to enhance its application value and promote the leap from scientific research to clinical practice
Research-grade specs Class: Small-molecule NNMT inhibitor (not a peptide) Molecular weight: 177 g/mol Vial size: 50 mg Format: Lyophilized powder Mechanism studied: NNMT inhibition and intracellular NAD availability Studied applications NNMT enzyme-inhibition research NAD pathway and cellular energy signalling studies Adipocyte metabolism research in cell culture Mitochondrial function and cellular aging marker studies Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Not sold or shipped outside the United States Storage & handling Store the vial refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Description BPC-157 + TB-500 Capsules 1000mcg (60ct) | Research Peptide Blend Frontier Peptide Labs BPC-157 + TB-500 Capsules are manufactured exclusively for laboratory research and scientific investigation
References to clinical trials and published research throughout this description are provided for informational and research context only and do not constitute medical claims or endorsements of any therapeutic application of these products.
This article is for informational purposes only and does not constitute medical advice
US$ 20.35
US$ 27.17
US$ 28.09
